Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital downgrades Lloyds after shares hit price target

(Sharecast News) - RBC Capital Markets downgraded Lloyds Banking Group on Friday to 'sector perform' from 'outperform' after the shares hit its 60p price target. RBC said that trading at around 1x 1 year-forward TBV, Lloyds now looks expensive relative to peers, and it believes that the re-rating story will be much tougher from here.

RBC said it was updating its estimates after the bank's second-quarter results this week and maintaining the price target.

"We continue to feel that LLOY is a well-managed bank with favourable strategic positioning, but we have run out of runway in valuation terms," it said.

"We did not downgrade to underperform due to: (i) the strength of the bank's deposit franchise, (ii) the certainty of momentum provided by the structural hedge, and (iii) a relatively attractive total return yield."

RBC sees asymmetric risk to the downside in the event of a bad outcome from the Financial Conduct Authority's review of motor finance.

"Pre-results consensus included circa £1.1bn in remediation charges for the issue versus our conservative base case of circa £2.5bn," it noted. "We expect that a soft outcome could represent a positive catalyst, but the reward is not worth the risk, in our view. There is also a high probability that September's announcement yields no clear outcome, with the can being kicked down the road, extending the period of uncertainty regarding this issue."

Share this article

Related Sharecast Articles

PepsiCo cuts revenue outlook again
(Sharecast News) - PepsiCo cut its annual organic revenue guidance again on Tuesday as it highlighted a "subdued" performance in North America in the third quarter.
Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.